SCHEMBL149959

SCHEMBL149959

C=C(C)C(=O)OCCN(C(C)C)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
THRB P10828 1/20 0.48
CHRM2 P08172 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
ALDH1A1 P00352 2/20 0.38
POLB P06746 2/20 0.36
APEX1 P27695 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CHRNB2 P17787 2/20 0.33
CHRNA4 P43681 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MCHR1 Q99705 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL8175854 0.95 TSHR (0.47) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL5140617 0.93 TSHR (0.50) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL345806 0.89 TSHR (0.53) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL5139803 0.87 THRB (0.42) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL16052928 0.87 THRB (0.50) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL27656516 0.87 TSHR (0.56) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL1250802 0.87 TSHR (0.50) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL28357664 0.86 TSHR (0.40) TSHRTHRBCHRM2CHRM1CHRM3
SCHEMBL28357663 0.85 TSHR (0.39) TSHRTHRBCHRM2CHRM1CHRM3
Acrylic Acid Ethyl Ester SCHEMBL10417508 0.85 THRB (0.44) TSHRTHRBCHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1984 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4732316-A1 MATERIALS AND METHODS OF PATHOGEN INACTIVATION C-Polar Technologies, Inc. (US) 2026-04-29 EP claimed
EP-4727588-A1 INTELLIGENT POLYMER-LIPID BASED NANO DRUG DELIVERY SYSTEM TO IMPROVE THE BBB-PENETRATION BY DUAL ACTIVE BRAIN TARGETING STRATEGIES Qurcan Therapeutics Inc. (CA) 2026-04-22 EP claimed
US-20260070002-A1 Multi-Modal Ion-Exchange Membranes for Rapid Separations UNIV CLEMSON (US) 2026-03-12 US claimed
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2026-02-12 US claimed
US-12508233-B2 Graft copolymers, methods of forming graft copolymers, and methods of use thereof VANDERBILT UNIVERSITY (US) 2025-12-30 US claimed
EP-4455168-B1 VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD CHT TURKEY KIMYA SANAYI VE TICARET A S (TR) 2025-12-24 EP claimed
EP-4646189-A1 POLYMERSOMES FOR DELIVERY OF NUCLEIC ACID CARGOES Vianautis Bio Limited (GB) 2025-11-12 EP claimed
US-12466899-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2025-11-11 US claimed
EP-4606840-A2 ISOCYANATE-FREE POLYURETHANE AND ISOCYANATE-FREE POLYURETHANE-CONTAINING POLYMERIC FILM PRODUCTION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2025-08-27 EP claimed
EP-3872573-B1 TONER ADDITIVE FORMULATION WITH CROSS-LINKED ORGANIC POLYMERIC ADDITIVE XEROX CORP (US) 2025-04-09 EP claimed
US-6083652-A DIISOPROPYLAMINOETHYL METHACRYLATE-METHYL METHACRYLATE COPOLYMER AND CONDUCTIVE FILLERS; DEVELOPERS XEROX CORPORATION (US) 2000-07-04 US claimed
US-6037091-A Carrier with ferrocene containing polymer XEROX CORPORATION (US) 2000-03-14 US claimed
US-6010812-A Coated carrier XEROX CORPORATION (US) 2000-01-04 US claimed
US-6004712-A CORE AND THEREOVER A POLYMER OF (1) METHYLMETHACRYLATE AND A MONOALKYL AMINOALKYL METHACRYLATE, OR (2) A POLYMER OF METHYLMETHACRYLATE AND DIALKYLAMINOALKYL METHACRYLATE, TONER AND DEVELOPER XEROX CORPORATION (US) 1999-12-21 US claimed
US-5945244-A Coated carrier XEROX CORPORATION (US) 1999-08-31 US claimed
US-5935750-A A CARRIER COMPOSED OF A CORE AND A COATING OF A POLYMER CONTAINING QUTERNARY AMMONIUM SALT GROUP AND CONTAINS A CONDUCTIVE COMPONENT XEROX CORPORATION (US) 1999-08-10 US claimed
EP-0420687-B1 Discoloration-resistant spandex DU PONT (US) 1996-06-19 EP claimed
US-5059647-A Discoloration inhibition E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-22 US claimed
EP-0420687-A2 Discoloration-resistant spandex E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-04-03 EP claimed
US-4895902-A COPOLYMER OF ACRYLIC ESTER AND DIISOPROPYLAMINO/ETHYL METHACRYLATE/2-/ E. I. DUPONT DE NEMOURS AND COMPANY (US) 1990-01-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF SMCHD1, VCL, FGB TSHR 4450/4885THRB 3507/4885CHRM2 1284/4885
US-12508233-B2 Graft copolymers, methods of forming graft copolymers, and methods of use thereof CHP1, NSF, LIPA TSHR 1915/4885THRB 3471/4885CHRM2 1861/4885
US-20260070002-A1 Multi-Modal Ion-Exchange Membranes for Rapid Separations TNFRSF9, CD40, CD2 TSHR 627/4885THRB 2366/4885CHRM2 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.